Ensemble learning-based pretreatment MRI radiomic model for distinguishing intracranial extraventricular ependymoma from glioblastoma multiforme.

Journal: NMR in biomedicine
PMID:

Abstract

This study aims to develop an ensemble learning (EL) method based on magnetic resonance (MR) radiomic features to preoperatively differentiate intracranial extraventricular ependymoma (IEE) from glioblastoma (GBM). This retrospective study enrolled patients with histopathologically confirmed IEE and GBM from June 2016 to June 2021. Radiomics features were extracted from T1-weighted imaging (T1WI) and T2-weighted imaging (T2WI) sequence images, and classification models were constructed using EL methods and logistic regression (LR). The efficiency of the models was assessed using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis. The combined EL model, based on clinical parameters and radiomic features from T1WI and T2WI images, demonstrated good discriminative ability, achieving an area under the receiver operating characteristics curve (AUC) of 0.96 (95% CI 0.94-0.98), a specificity of 0.84, an accuracy of 0.92, and a sensitivity of 0.95 in the training set, and an AUC of 0.89 (95% CI 0.83-0.94), a specificity of 0.83, an accuracy of 0.81, and a sensitivity of 0.74 in the validation set. The discriminative efficacy of the EL model was significantly higher than that of the LR model. Favorable calibration performance and clinical applicability for the EL model were observed. The EL model combining preoperative MR-based tumor radiomics and clinical data showed high accuracy and sensitivity in differentiating IEE from GBM preoperatively, which may potentially assist in clinical management of these brain tumors.

Authors

  • Haoling He
    Department of Radiology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Qianyan Long
    Department of Radiology, Xiangya Hospital, Central South University, Changsha, China.
  • Liyan Li
    Medical School, Huanghe Science & Technology University, Zhengzhou 450063, PR China; College of Medicine, Zhengzhou University, Zhengzhou 450001, PR China; Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Huanghe Science & Technology University, Zhengzhou 450063, PR China.
  • Yan Fu
    School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, PR China. Electronic address: fuyan@tju.edu.cn.
  • Xueying Wang
    Institute of Intelligent System and Bioinformatics, College of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.
  • Yuhong Qin
    Department of Radiology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Muliang Jiang
    Department of Radiology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Zeming Tan
    Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
  • Xiaoping Yi
    Department of Radiology, Xiangya Hospital, Central South University, Changsha, China.
  • Bihong T Chen
    Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States. Electronic address: Bechen@coh.org.